miR-24 overexpression blocked Chi3l1 induction in vivo, limiting AAA expansion, while anti-miR-24 led to higher Chi3l1 expression and development of larger, rupture-prone aneurysms. Here, CHI3L1 is linked to triple-A syndrome.